Mankind Pharma Allots Shares Under ESOPs

Authored By Ankur Chandra | Last Modified: May 31, 2025 10:45 PM IST

Open Free Demat Account

Mankind Pharma Limited has announced the allotment of 92,512 equity shares under its Employee Stock Option Plan 2022 (ESOP 2022). The shares were granted to eligible employees who exercised their stock options, as per the resolution passed by the Nomination and Remuneration Committee during its meeting held on May 21.

Key Highlights of the Allotment:

Particulars	Details
Number of shares allotted	92,512
Face value per share	₹1
Exercise price per share	₹860
Premium per share	₹859
Post-allotment total equity shares	41,26,71,039
Increase in paid-up share capital	From ₹41,25,78,527 to ₹41,26,71,039
ISIN	INE634S01028
Distinctive numbers	41,25,78,528 to 41,26,71,039

All the newly issued equity shares will rank pari-passu with the existing equity shares of the company, carrying equal rights and entitlements.

The ESOP allotment was executed following Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company confirmed that there is no lock-in period on the allotted shares, and no listing fees are applicable for this issue. The equity shares will continue to be listed and traded on both the NSE and BSE.

Stock Performance:

Shares of Mankind Pharma have gained 21% in the last year, a 12% dip in the YTD, and a 2.27% dip in the last month.

About Mankind Pharma:

Mankind Pharma, an Indian multinational based in New Delhi, is one of the top pharmaceutical companies in India with a diverse product portfolio ranging from Pharma to FMCG. The company’s trusted products help millions around the world in critical areas such as antibiotics, gastrointestinal, cardiovascular, and skin health.

Ref:https://nsearchives.nseindia.com/corporate/MANKIND4_21052025104750_ESOPallotment21052025_sd.pdf

Business News